TATA-box-binding protein-associated factor 15 is a novel biomarker that promotes cell proliferation and migration in gastrointestinal stromal tumor

被引:0
作者
Cheng-Ming Guo [1 ]
Li Tang [1 ]
Xu Li [1 ]
Liu-Ye Huang [1 ]
机构
[1] Department of Gastroenterology,The Affiliated Yantai Yuhuangding Hospital of Qingdao University
基金
中国国家自然科学基金;
关键词
D O I
暂无
中图分类号
R735 [消化系肿瘤];
学科分类号
100214 ;
摘要
BACKGROUND Gastrointestinal stromal tumor(GIST) is a common neoplasm with high rates of recurrence and metastasis,and its therapeutic efficacy is still not ideal. There is an unmet need to find new molecular therapeutic targets for GIST. TATA-boxbinding protein-associated factor 15(TAF15) contributes to the progress of various tumors,while the role and molecular mechanism of TAF15 in GIST progression are still unknown.AIM To explore new molecular therapeutic targets for GIST and understand the biological role and underlying mechanisms of TAF15 in GIST progression.METHODS Proteomic analysis was performed to explore the differentially expressed proteins in GIST. Western blotting and immunohistochemical analysis were used to verify the expression level of TAF15 in GIST tissues and cell lines. Cell counting kit-8,colony formation,wound-healing and transwell assay were executed to detect the ability of TAF15 on cell proliferation,migration and invasion. A xenograft mouse model was applied to explore the role of TAF15 in the progression of GIST.Western blotting was used to detect the phosphorylation level and total level of RAF1,MEK and ERK1/2.RESULTS A total of 1669 proteins were identified as differentially expressed proteins with 762 upregulated and 907 downregulated in GIST. TAF15 was selected for the further study because of its important role in cell proliferation and migration.TAF15 was significantly over expressed in GIST tissues and cell lines. Overexpression of TAF15was associated with larger tumor size and higher risk stage of GIST. TAF15 knockdown significantly inhibited the cell proliferation and migration of GIST in vitro and suppressed tumor growth in vivo. Moreover,the inhibition of TAF15 expression significantly decreased the phosphorylation level of RAF1,MEK and ERK1/2 in GIST cells and xenograft tissues,while the total RAF1,MEK and ERK1/2 had no significant change.CONCLUSION TAF15 is over expressed in GIST tissues and cell lines. Overexpression of TAF15 was associated with a poor prognosis of GIST patients. TAF15 promotes cell proliferation and migration in GIST via the activation of the RAF1/MEK/ERK signaling pathway. Thus,TAF15 is expected to be a novel latent molecular biomarker or therapeutic target of GIST.
引用
收藏
页码:2932 / 2949
页数:18
相关论文
共 19 条
  • [1] Clinical outcomes and prognostic factors for patients with high-risk gastrointestinal stromal tumors treated with 3-year adjuvant imatinib
    Bang, Yeong Hak
    Ryu, Min-Hee
    Kim, Hyung-Don
    Lee, Hyung Eun
    Kang, Yoon-Koo
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2022, 151 (10) : 1770 - 1777
  • [2] LncRNA LINC00649 recruits TAF15 and enhances MAPK6 expression to promote the development of lung squamous cell carcinoma via activating MAPK signaling pathway
    Zhu, Huaiyang
    Liu, Qingyuan
    Yang, Xiaobo
    Ding, Caihong
    Wang, Qing
    Xiong, Yu
    [J]. CANCER GENE THERAPY, 2022, 29 (8-9) : 1285 - 1295
  • [3] Wang Jixiang,Cai Ying,Lu Hui,Zhang Fugeng,Zheng Junyi.LncRNA APOA1-AS facilitates proliferation and migration and represses apoptosis of VSMCs through TAF15-mediated SMAD3 mRNA stabilization[J].Cell cycle (Georgetown, Tex.),2021
  • [4] Ullah Rahim,Yin Qing,Snell Aidan H,Wan Lixin.RAF-MEK-ERK pathway in cancer evolution and treatment[J].Seminars in cancer biology,2021
  • [5] Loci-specific phase separation of FET fusion oncoproteins promotes gene transcription
    Zuo, Linyu
    Zhang, Guanwei
    Massett, Matthew
    Cheng, Jun
    Guo, Zicong
    Wang, Liang
    Gao, Yifei
    Li, Ru
    Huang, Xu
    Li, Pilong
    Qi, Zhi
    [J]. NATURE COMMUNICATIONS, 2021, 12 (01)
  • [6] Li Shuliang,Chen Daming,Li Shilong,Zhao Zongxian,Yang Huaxiang,Wang DaoHan,Zhang Zhaoxiong,Fu Weihua.Novel Prognostic Nomogram for Recurrence-Free Survival of Patients With Primary Gastrointestinal Stromal Tumors After Surgical Resection: Combination of Prognostic Nutritional Index and Basic Variables
[J].Frontiers in Oncology,2021
  • [7] BDNF expression in GISTs predicts poor prognosis when associated with PD-L1 positive tumor-infiltrating lymphocytes
    Tian, Guang-Ang
    Xu, Wen-Ting
    Sun, Yue
    Wang, Jin
    Ke, Qing
    Yuan, Meng-Jiao
    Wang, Jin-Jin
    Zhuang, Chun
    Gong, Qian
    [J]. ONCOIMMUNOLOGY, 2021, 10 (01):
  • [8] Keung Emily Z,Raut Chandrajit P,Rutkowski Piotr.The Landmark Series: Systemic Therapy for Resectable Gastrointestinal Stromal Tumors[J].Annals of surgical oncology,2020
  • [9] Hemming M L,Heinrich M C,Bauer S,George S.Translational insights into gastrointestinal stromal tumor and current clinical advances[J].Annals of oncology : official journal of the European Society for Medical Oncology,2018
  • [10] α-Amanitin Restrains Cancer Relapse from Drug-Tolerant Cell Subpopulations via TAF15
    Kume, Kohei
    Ikeda, Miyuki
    Miura, Sawako
    Ito, Kohei
    Sato, Kei A.
    Ohmori, Yukimi
    Endo, Fumitaka
    Katagiri, Hirokatsu
    Ishida, Kaoru
    Ito, Chie
    Iwaya, Takeshi
    Nishizuka, Satoshi S.
    [J]. SCIENTIFIC REPORTS, 2016, 6